Literature DB >> 19444381

Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Sevki Sahin1, Sibel Karsidag, Sunay Ayalp, Ahmet Sengul, Onder Us, Kubilay Karsidag.   

Abstract

Recent studies have shown that impaired glucose tolerance (IGT) is associated with dysfunction in the peripheral and autonomic nerves. The aim of this study was to determine the electrophysiological abnormalities of IGT. To determine electrophysiological abnormality in the large sensorimotor and sudomotor autonomic nerves with IGT patients, 43 patients and 34 healthy subjects have been studied. Subjective neuropathy symptoms, neurological examination and the electrophysiological findings were evaluated. When conduction of large somatic fibers only was evaluated, the ratio of electrophysiological abnormality was found to be 21%. In addition, where sympathetic skin response was evaluated the sudomotor autonomic abnormality ratio was 28% in upper extremities, 53% in lower extremities, and 16% in upper and lower extremities together. The percentages of abnormal electrophysiological parameters in different motor and sensory nerves were 39.5% in the peroneal motor nerve, 20.9% in the median motor and sural sensory nerves, 18.6% in the median sensory nerve, 16.3% in the tibial motor nerve, 14% in the ulnar sensory nerve, and 2.3% in the ulnar motor nerve. While distal motor latency was the most frequent abnormal parameter in the median and tibial motor nerves, the amplitude changes in the peroneal and ulnar motor nerves were also prominent. In sensory evaluation, the onset latency in the median-ulnar sensory nerves and the amplitude in the sural sensory nerve were found to be evident abnormalities.

Entities:  

Mesh:

Year:  2009        PMID: 19444381     DOI: 10.1007/s10072-009-0089-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  43 in total

1.  Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.

Authors:  Yuichi Murakawa; Weixian Zhang; Christopher R Pierson; Tom Brismar; Claes-Göran Ostenson; Suad Efendic; Anders A F Sima
Journal:  Diabetes Metab Res Rev       Date:  2002 Nov-Dec       Impact factor: 4.876

2.  Peripheral neuropathy with impaired glucose tolerance: a sweet smell of success?

Authors:  John T Kissel
Journal:  Arch Neurol       Date:  2006-08

3.  Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds.

Authors:  G Bax; C Fagherazzi; F Piarulli; A Nicolucci; D Fedele
Journal:  Diabetes Care       Date:  1996-08       Impact factor: 19.112

4.  Early peripheral nerve abnormalities in impaired glucose tolerance.

Authors:  A Cappellari; L Airaghi; R Capra; A Ciammola; A Branchi; G Levi Minzi; N Bresolin
Journal:  Electromyogr Clin Neurophysiol       Date:  2005-06

5.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

6.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

7.  Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization.

Authors:  G Puavilai; S Chanprasertyotin; A Sriphrapradaeng
Journal:  Diabetes Res Clin Pract       Date:  1999-04       Impact factor: 5.602

8.  The natural history of recently diagnosed autonomic neuropathy over a period of 2 years.

Authors:  D T Karamitsos; T P Didangelos; V G Athyros; A G Kontopoulos
Journal:  Diabetes Res Clin Pract       Date:  1998-10       Impact factor: 5.602

Review 9.  Microvascular complications of impaired glucose tolerance.

Authors:  J Robinson Singleton; A Gordon Smith; James W Russell; Eva L Feldman
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

Review 10.  Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.

Authors:  Peter J Dyck; P James B Dyck; Christopher J Klein; Stephen D Weigand
Journal:  Muscle Nerve       Date:  2007-10       Impact factor: 3.217

View more
  5 in total

1.  Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy.

Authors:  Mitra Tavakoli; Omar Asghar; Uazman Alam; Ioannis N Petropoulos; Hassan Fadavi; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

2.  An observational study assessing peripheral neuropathy related to multiple myeloma.

Authors:  C Leone; V Federico; S La Cesa; E Russo; G Di Stefano; P Finsinger; R Labriola; G Cruccu; M T Petrucci; A Truini
Journal:  Neurol Sci       Date:  2016-03-09       Impact factor: 3.307

Review 3.  Prevalence of peripheral neuropathy in pre-diabetes: a systematic review.

Authors:  Varo Kirthi; Anugraha Perumbalath; Emily Brown; Sarah Nevitt; Ioannis N Petropoulos; Jamie Burgess; Rebecca Roylance; Daniel J Cuthbertson; Timothy L Jackson; Rayaz A Malik; Uazman Alam
Journal:  BMJ Open Diabetes Res Care       Date:  2021-05

4.  Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes - ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS).

Authors:  Bin Lu; Ji Hu; Jian Wen; Zhaoyun Zhang; Linuo Zhou; Yiming Li; Renming Hu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

5.  How the impact of median neuropathy on sensorimotor control capability of hands for diabetes: an achievable assessment from functional perspectives.

Authors:  Haw-Yen Chiu; Hsiu-Yun Hsu; Li-Chieh Kuo; Fong-Chin Su; Hui-I Yu; Shih-Che Hua; Chieh-Hsiang Lu
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.